ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

517 hedge funds and large institutions have $30.2B invested in Alexion Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 192 increasing their positions, 210 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
517
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
14
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$198M
Puts
$161M
Net Calls
Net Calls Change

Top Buyers

1 +$260M
2 +$130M
3 +$79M
4
Millennium Management
Millennium Management
New York
+$72.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$40.2M

Top Sellers

1 -$188M
2 -$118M
3 -$89.4M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$77M
5
Goldman Sachs
Goldman Sachs
New York
-$59.6M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$228M
27
$205M
28
$190M
29
$171M
30
$154M
31
$144M
32
$142M
33
$138M
34
$131M
35
$130M
36
$128M
37
$127M
38
$121M
39
$108M
40
$93.3M
41
$91.5M
42
$90.9M
43
$88.7M
44
$86.7M
45
$83.9M
46
$83.7M
47
$83.5M
48
$82.5M
49
$79.3M
50
$78.1M